drugset / Trial / NCT00293462

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

NCT00293462

RandomizedCrossoverDouble-blindSupportive care

Summary

GM-CSF may protect normal cells from the side effects, such as mucositis, of radiation therapy and may help damaged tissue heal faster after radiation therapy. This randomized clinical trial is studying how well GM-CSF works in preventing and treating mucositis in patients who are undergoing radiation therapy for head and neck cancer.

Timeline

Start
2005-06-07
Primary completion
2009-12-31
Completion
2009-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator sargramostim Protein / enzyme biologic Oral